a.ostergaard
Submits third-party assay reports on material purchased directly. Based in Coimbra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.07%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043540 | GHRP-2 | SIG | SIG-2603-6031 | PeptideMeter | 2026-Q3 | 98.60 | 1.36 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-041391 | BPC-157 | QYB | QYB-2601-D3993 | PeptideMeter | 2026-Q2 | 99.93 | 4.35 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042804 | Retatrutide | GGPeps | GGPE-2512-D2133 | Janoshik | 2026-Q2 | 98.35 | 3.66 | 105.2 | Buyer-sourced | 0 | PASS |
| AX-2026-041517 | TB-500 | QSC | QSC-2601-V6086 | Janoshik | 2026-Q2 | 99.93 | 4.09 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041240 | Retatrutide | WWB | WWB-2510-H1662 | PeptideMeter | 2026-Q1 | 98.96 | 4.70 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018562 | Tirzepatide | QYB | QYB-2507-T4628 | Janoshik | 2025-Q4 | 99.15 | 5.84 | 93.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019174 | TB-500 | SinoPep | SNP-2505-V3856 | VendorInvestigate | 2025-Q2 | 98.99 | 4.47 | 95.9 | Buyer-sourced | 0 | PASS |
| AX-2024-004216 | Liraglutide | WWB | WWB-2406-R3462 | VendorInvestigate | 2024-Q3 | 99.07 | 1.34 | 97.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004157 | Desmopressin | WWB | WWB-2312-E2908 | Janoshik | 2024-Q1 | 99.64 | 5.87 | 101.1 | Buyer-sourced | 0 | PASS |